Your browser doesn't support javascript.
Effect of Lianhua Qingwen capsules on the positive rate of COVID-19 close contacts: A retrospective analysis of a large-scale population-based cohort study.
Qiao, Yunfeng; Xu, Xiaolong; Zhou, Fangfang; Wang, Ke; Li, Mingxian; Liu, Chaoying; Chen, Zhiying; Yin, Ping; Shi, Yifan; Wang, Yongjie; Liu, Qingquan.
  • Qiao Y; Jilin Province People's Hospital, Changchun 130000, PR China.
  • Xu X; Beijing hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, PR China.
  • Zhou F; Huazhong University of Science and Technology, Wuhan 430030, PR China.
  • Wang K; The Second Hospital of Jilin University, Changchun 130000, PR China.
  • Li M; The First Hospital of Jilin University, Changchun 130000, PR China.
  • Liu C; The First Hospital of Jilin University, Changchun 130000, PR China.
  • Chen Z; China-Japan Union Hospital of Jilin University, Changchun 130000, PR China.
  • Yin P; Huazhong University of Science and Technology, Wuhan 430030, PR China.
  • Shi Y; Beijing hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, PR China.
  • Wang Y; Jilin Province People's Hospital, Changchun 130000, PR China. Electronic address: 1479706712@qq.com.
  • Liu Q; Beijing hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, PR China. Electronic address: liuqingquan_2003@126.com.
Phytomedicine ; 112: 154690, 2023 Apr.
Article in English | MEDLINE | ID: covidwho-2244410
ABSTRACT

OBJECTIVE:

Coronavirus disease 2019 (COVID-19) is still spreading worldwide. COVID-19 close contact is a key point of this epidemic. However, no medication is now available for close contact. This study aims to evaluate the beneficial effect and safety of the Lianhua Qingwen capsule (LHQW) on COVID-19 close contacts via a large, retrospective cohort study.

METHODS:

A total of 25,002 close contacts from 199 quarantine sites in Changchun, Jilin, who underwent medical observation, were included. The information about these close contacts were collected for further epidemiological research. Moreover, subjects were divided into an exposure group (LHQW group, oral, 4 capsules/time, t.i.d.; 18,579 subjects) and a non-exposure group (control group; 6,423 subjects). Inverse probability of treatment weighting (IPTW) with propensity score was employed to evaluate the positive rate of the SARS-CoV-2 nucleic acid test in nasal and throat swabs confirmed by polymerase chain reaction (PCR).

RESULTS:

A total of 22,975 subjects were included in the analysis, 17,286 cases in the LHQW group and 5,689 cases in the control group. The positive rate of nucleic acid testing in the LHQW group was 5.12%, and that in the control group was 9.70% before the adjustment of IPTW of the propensity score; the difference between the two groups was -4.58% (95% CI -5.44- -3.77%, p <  0.001). After adjusting IPTW, the positive rate of nucleic acid testing in the LHQW group and the control group was 5.10% and 9.80%, respectively; the difference between the two groups was -4.70% (95% CI -5.18- -4.23, p < 0.001). The conclusions before and after the IPTW adjustment were consistent. No test drug-related adverse reactions were observed during the study period.

CONCLUSION:

LHQW has a beneficial effect and safety on the close contacts of SARS-CoV-2 who are under medical observation at the quarantine sites and can be used as an optional drug for those close contacts.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Phytomedicine Journal subject: Complementary Therapies Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Phytomedicine Journal subject: Complementary Therapies Year: 2023 Document Type: Article